Hot Topics

view more
article-block

The printer that uses “lightsabres” to 3D-print cells and scaffolds to revolutionise research

11 April 2025 -- Birmingham, UK -- In the latest episode of the Aston Originals podcast What is a membrane?, Dr Emma Shepherd, Dr Dominic Mosses and Dr David Jenkins join host Dr Matt Derry to explain the workings and potential of Aston University’s Quantum X bio printer.

 10 April 2025
article-block

Shockwave Medical Enrols First Patient in Study of Forward Intravascular Lithotripsy Platform

7 April 2025 -- California, US -- Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, announced it has initiated its pivotal FORWARD CAD investigational device exemption (IDE) study. Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.

 6 April 2025
article-block

CordenPharma Becomes Supplier Partner of the PSCI (Pharmaceutical Supply Chain Initiative)

27 March 2025 -- Basel, Switzerland -- We are excited to announce that as of March 2025, after successfully fulfilling the requirements for supplier partnership, CordenPharma have been selected to become a Supplier Partner in the second cohort of the PSCI (Pharmaceutical Supply Chain Initiative).

 27 March 2025
article-block

Adragos Pharma Expands in Japan: Strengthening Production, Quality, and Trust

14 March 2025 -- Tokyo, Japan -- Adragos Pharma is actively seeking to expand its presence in Japan, focusing significantly on enhancing its production capabilities at the Kawagoe site in Saitama Prefecture.

 14 March 2025
article-block

PerkinElmer Acquires Project Farma, Expanding Its Services Offering for the Life Sciences Industry

11 March 2025 -- Connecticut, US -- PerkinElmer today announced the acquisition of Project Farma, a subsidiary of Precision for Medicine. Project Farma is a leading life sciences consultancy focused on advancing technical operations from ideation through commercialization, offering project management, project controls, commissioning, qualification and validation, quality compliance and engineering consulting services.

 11 March 2025
article-block

L.B. Bohle's US Debut of Pharma Market’s First Wet Granulator with Integrated Continuous Dryer

10 February 2025 -- Pennsylvania, US -- L.B. Bohle, a longstanding manufacturer and supplier of high-quality processing solutions for pharmaceutical solids, will showcase a first-of-its-kind truly continuous granulator and dryer at INTERPHEX NYC, April 1-3.

 10 February 2025

Product Profile

view more
article-category

PR No2 enables quick and easy IR detection

A second edition of the LASER COMPONENTS Pyroelectric Receiver series is now available!

Product Profile, 11 March 2025
article-category

Small and flexible – FLEXPOINT® MVpico (Edition 2025)

When you are limited in space and weight, FLEXPOINT® MVpico laser modules with a uniform line from LASER COMPONENTS guarantee a high performance. These small line laser modules come at various wavelengths from 405 to 850nm and with an output power up to 100mW, suitable for many applications.

Product Profile, 5 March 2025
article-category

High-Power Fibre Lasers and Amplifiers from Cybel

LASER COMPONENTS is pleased to announce that Cybel's fibre lasers and amplifiers are now available to customers in the medical, aerospace, defense, quantum technology and LiDAR industries. Products by this US-based manufacturer are used in applications that require precisely preset wavelengths.

Product Profile, 26 February 2025
article-category

New Ultra-low Jitter Clock Recovery Instrument

Synchronising high-speed data is challenging due to the need for precise timing and minimal jitter, which can significantly impact signal integrity and overall system performance. LASER COMPONENTS is pleased to offer Quantifi’s new QCR series clock recovery instrument which addresses these challenges by providing high-quality precision timebase clock recovery with ultra-low jitter noise down to 180fs (rms).

Product Profile, 10 February 2025
article-category

ep Dualfilter T.I.P.S.® - Effective Protection from Bio-Aerosols

5 December 2024 -- Hamburg, Germany -- Bio-aerosols aren’t welcome in any laboratory. They can consist of bacteria, cell fragments, fungal spores or viruses, as well as byproducts of microbial metabolism. Aerosols are easily generated in various concentrations during simple routine tasks in the laboratory, such as centrifugation, pipetting or shaking.

Product Profile, 5 December 2024

Press Releases

view more
article-category

AnalytiChem introduces Redipor ready-to-use culture media brand globally

24 April 2025 -- Eschborn, Germany -- AnalytiChem, manufacturer of specialized laboratory equipment, reagents and consumables, has introduced Redipor ready-to-use culture media as an AnalytiChem branded product line globally.

Press Releases, 23 April 2025
article-category

CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA

22 April 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).

Press Releases, 21 April 2025
article-category

Nuclera expands eProtein Discovery capabilities to enable membrane protein production

14 April 2025 -- Cambridge, UK and Massachusetts, US -- Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery system, today announced the addition of a new membrane protein workflow to its system.

Press Releases, 13 April 2025
article-category

The printer that uses “lightsabres” to 3D-print cells and scaffolds to revolutionise research

11 April 2025 -- Birmingham, UK -- In the latest episode of the Aston Originals podcast What is a membrane?, Dr Emma Shepherd, Dr Dominic Mosses and Dr David Jenkins join host Dr Matt Derry to explain the workings and potential of Aston University’s Quantum X bio printer.

Press Releases, 10 April 2025
article-category

Shionogi's real-world data; better clinical outcomes when Fetcroja is used as documented therapy

8 April 2025 -- Osaka, Japan -- Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President & CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) presents new European data from its largest real-world evidence study of Fetroja®/Fetcroja® (cefiderocol), an innovative siderophore cephalosporin at the 35th Congress of the European Society of Clinical Microbiology and Infectious Diseases in Vienna on 11th-15th April 2025.

Press Releases, 7 April 2025

Digital

view more
article-category

AI-powered pharma in 2025: faster drugs, safer patients, smarter healthcare

Digital tools, such as artificial intelligence, are improving pharma drug discovery

Digital, 17 March 2025
article-category

How technology will shape pharma in 2025

How will advancements in technology affect the pharma sector, from both commercial and R&D points of view?

Digital, 17 March 2025
article-category

Transforming pharmaceutical manufacturing with cyber-physical trust

James Kugler at EMD Digital/Merck speaks to IPT about how counterfeit drugs, regulatory pressures and supply chain vulnerabilities demand a greater level of transparency in pharmaceutical manufacturing. Cyber-physical trust platforms, which provide an immutable link between physical products and their digital twins, will set a new standard and revolutionise the industry

Digital, 17 March 2025
article-category

Transforming pharma companies for customer-centricity

The world is rapidly changing with numerous and frequent digital transformations. How can these be implemented and utilised effectively to ensure customer-centricity in the pharma sector?

Digital, 6 December 2024
article-category

The future of generative AI and automation in drug discovery

How is generative AI being utilised in drug discovery to improve processes and secure higher-quality drugs?

Digital, 6 December 2024

Manufacturing

view more
article-category

Multi-tip tooling: a guide

What are some challenges with multi-tip tooling, and how can these be overcome?

article-category

Cell processing platforms in biologics therapeutics manufacturing

Julien Muzard at Entegris speaks to IPT about how innovations in downstream cell processing platforms will improve biologics therapeutics manufacturing, and the impact artificial intelligence will have on the sector

article-category

CARBOGEN AMCIS

article-category

Driving innovation with purpose: our vision, values and expertise

CARBOGEN AMCIS is a leading global contract development and manufacturing organisation (CDMO), trusted by pharmaceutical and biopharmaceutical companies worldwide. With over 40 years of expertise, the company offers an integrated suite of services across drug substance and drug product development, helping clients to bring life-changing therapies to market with precision and efficiency.

article-category

Drug substance: from bench to market

With a strong track record in complex chemistry, CARBOGEN AMCIS offers end-to-end drug substance solutions, from preclinical development to commercial supply.

article-category

World-class drug product capabilities: from formulation to commercialisation

Our expertise in drug product development encompasses a wide range of pharmaceutical services. From formulation design to commercial-scale manufacturing, we specialise in efficiently bringing your drug product to market while ensuring full compliance with regulatory standards. Our highly skilled team at our state-of-the-art facility in Saint-Beauzire, France, ensures that your drug product is manufactured with precision and meets the highest quality standards.

article-category

Expertise in fine chemicals, cholesterol/vitamin D manufacturing

CARBOGEN AMCIS’ Manchester, UK, site plays a crucial role in early-phase drug development, providing high-quality starting materials and building blocks across industries, including pharmaceuticals, cosmetics, electronics and dental applications.

article-category

Comprehensive solutions for tablet and capsule manufacturing

Discover how natoli engineering empowers the pharmaceutical industry with innovative equipment, expert training, and unparalleled customer support and expertise. We are the global leader in tablet compression tooling. Our commitment to the tablet compression industry is demonstrated through the development of groundbreaking solutions and progressive, continual improvements in our manufacturing processes. Partner with us – we are better together!

article-category

Powering pharma innovation: building a workforce for the future

What are some leadership and human resource strategies critical to success in the pharma cdmo sector, including best practices, emerging trends and challenges in managing talent within a highly competitive and evolving industry?

article-category

Why the pharmaceutical industry is embracing continuous manufacturing

Batch manufacturing has been the standard in the pharma industry, however continuous manufacturing is now proving to be the better choice for efficiency, as well as waste and cost reduction. How can new technologies improve this method further?

article-category

SPOTLIGHT: The Natoli NCF-45 capsule filling machine – engineered for your success

In the fast-paced world of pharmaceutical manufacturing, efficiency and precision are non-negotiable. For manufacturers dealing with difficult-to-encapsulate powders and formulations, the Natoli NCF-45 Capsule Filling Machine emerges as a game changer. With the potential to pay for itself in the powder you’ll save, the NCF-45 isn’t just a machine, it’s an investment in better yields and greater profits. Better yields = better profits

article-category

Don’t let complexity and manual processes slow down your ability to control costs and...

There are usually two parameters important to pharmaceutical manufacturers: time and money. Is everything still on schedule? And are they still on budget? They need non-stop insight

article-category

The regulatory headache: advanced monitoring technologies can provide pain relief

Focusing on regulation within pharmaceutical manufacturing can help re-centre a company’s priorities, while ensuring compliance. This can be aided by the use of advanced monitoring techniques

article-category

Hand-in-hand: good manufacturing practice and stability studies

Following good manufacturing practices (GMP) is crucial for stability testing. The analytical data generated from stability studies is a pivotal part of a regulatory dossier submission to substantiate the shelf life claimed for the drug product or drug substance and further support that shelf-life post-approval. All aspects of the stability study must be executed to the highest level of quality to ensure...

article-category

Protein-based immunotherapies – the journey from discovery to manufacturing

Protein-based immunotherapies, such as monoclonal antibodies and adoptive cell transfer therapies, are reshaping oncology treatments, but ensuring their safety and efficacy is crucial for their success

article-category

Addressing the UK government’s new initiative on medical device equity

Medical devices should be designed with an awareness of the challenges of a specific disease as well as an awareness of equality, and the uk government has recently produced a new initiative around this, but how will this impact medical device production going forward?

Lab Design

view more
article-category

Robotic automation in the pharma lab

IPT talks to Roya Amini-Naieni at Trilobio about robotic automation in pharma research, the different applications of soft-and hardware, and how the field is likely to develop over the next five years

article-category

Automated labs: the future of drug R&D

IPT talks to David Fuller at Artificial Inc about how automated labs are revolutionising the pharma R&D space by connecting disparate systems, easing the burden of manual tasks on workers, and speeding up time-to-market with tools such as artificial intelligence

article-category

Rapid microbiological monitoring: transforming environmental monitoring in pharma manufacturing

Ensuring a manufacturing environment stays clear of bacteria and fungi is of utmost importance, especially when it comes to pharmaceuticals. How can this highly specialised monitoring be achieved in a fast, cost-effective manner?

article-category

One cannot leverage AI without a connected laboratory

A connected laboratory, where systems and devices communicate seamlessly, is the foundation to unlock AI’s full capabilities

article-category

The journey to full automation – for labs of all sizes

With the lab of the future becoming increasingly automated, how will this change workflows and how can the industry prepare for this?

article-category

Bridging the gap: Integrating legacy equipment for modular production

The pharmaceutical sector is characterised by intricate processes, stringent regulations and a constant demand for innovation. However, the industry's digital transformation is hindered by the prevalence of legacy machinery, which often poses compatibility challenges when deploying new technology. COPA-DATA explains the method of standardisation to remove the barriers of integration of legacy equipment in labs and production lines

article-category

Lab automation: the future of life sciences

'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs

article-category

Automation holds the key to unlocking the Lab of the Future

Lab layouts, until the introduction of automation, had seen little change in decades. However, the increased usage of hardware and software lab automation has reduced repetitive manual tasks and drastically increased the walkaway time involved in experiments

article-category

Five Steps to Successful AI

Whether lab managers are enthusiastic or apprehensive, AI is coming to the lab. The key to building this advantage is not in the technology, but the approach. Successful adoption of AI requires a genuine, long-term commitment. IPT spoke to Bob Voelkner at LabVantage Solutions about the implications of AI for pharma, what it takes to succeed with this new technology and his five recommended steps for getting started

article-category

LabVantage Solutions Company Profile

LabVantage Solutions’ Pharmaceutical LIMS is Engine for Digital Transformations

article-category

The Importance of Network Integration for Measurement and Hygiene Technology Solutions

Healthcare and scientific facilities are critical for the health of the global population. During the COVID-19 pandemic, scientific facilities helped to deliver life-saving vaccines, re-emphasising their importance in achieving other scientific milestones in the coming decades

article-category

Next-Level Digitalisation: Smart Pharma Production Gets Even Smarter

The digitalisation of pharmaceutical manufacturing has come a long way. However, there are still many ways companies can improve systems to grow even further

article-category

Three Lessons Pharma Can Learn From Manufacturing to Become a Leader in Automation

Pharmaceutical companies face plenty of challenges throughout the manufacturing cycle. Automation can be the key to bringing the industry to the forefront of this exciting field

article-category

AI, 3D Reconstruction, and Robotics in Clinical Phlebotomy

IPT speaks to Toon Overbeeke of Vitestro about the potential benefits of using robots in clinics to draw blood from patients. With a shortage of clinical staff all over Europe, Toon believes robotics is the way forward regarding individual clinical patient care

article-category

The Future of Digitalisation in the Lab

IPT speaks to Mikael Hagstroem, CEO of LabVantage Solutions, about the ongoing potential for laboratories of adopting AI and machine learning (ML)

article-category

The Changing Face of Quality Management

Smart automation is enabling new ways to monitor and intervene pre-emptively in pharma manufacturing. Find out the views of industry experts, who debated the subject in a roundtable video discussion.

Discovery and Development

view more
article-category

Exploring new dimensions with spatial multi-omics

The implementation of spatial technologies advances disease research, but challenges must be overcome before spatial multi-omics becomes broadly accessible

Discovery and Development, 17 March 2025
article-category

The evolution and future of DNA sequencing

The evolution of DNA sequencing – from Sanger to cutting-edge next generation approaches like Illumina, Nanopore and Single Molecule, Real-Time (PacBio) sequencing – has brought advances in speed, cost and accessibility. However, what challenges are faced in throughput scale-up, and what promise does automation hold for transforming genomics and personalised medicine?

Discovery and Development, 17 March 2025
article-category

Overcoming delivery barriers to unlock the full potential of RNA-based medicine

While RNA molecules have demonstrated promising results as therapeutics for difficult-to-treat disease indications, their current limitations in terms of delivery mean their full potential is not being realised. How can this be overcome?

Discovery and Development, 17 March 2025
article-category

The use of genetic information in precision medicine

The pharma industry needs a way to ensure the right therapies are getting to the right patients, in a timely and cost-effective way. How are advances in researchers’ understanding of genomics aiding not only precision medicine for rare diseases, but also for common health conditions?

Discovery and Development, 17 March 2025
article-category

Advancing cell line development: how next-gen innovation meets industry needs

Cell line development is integral to research and biotherapeutic production, and so ensuring this process is as robust as possible through next-generation technology is in the industry’s best interests

Discovery and Development, 6 December 2024

Imaging and Sensing

view more
article-category

mmc2025 (incorporating EMAG 2025): registration officially OPEN!

One of the biggest events of its kind in Europe, mmc2025 (incorporating EMAG 2025) will bring you the very best in microscopy, imaging and cytometry from across the globe.

Analytics, 17 March 2025
article-category

At-line protein quantification: the quest for realtime data in biologic and viral vector development

Ruizhi Wang at Abselion talks to IPT about how non-optical sensor technologies are unlocking critical process data at the bench and bioreactor

Analytics, 17 March 2025
article-category

Overcoming challenges in bispecific antibody production with chromatography & purification solutions

Bispecific antibodies are revolutionising biotherapeutic development, offering enhanced efficacy by targeting two antigens simultaneously. However, their structural complexity presents significant purification challenges. Advances in mixed-mode chromatography and scalable purification strategies are optimising production, improving yield, purity and cost efficiency, while ensuring a seamless transition from research to commercial manufacturing

Analytics, 17 March 2025
article-category

2025 RMS Section Awards: winners announced!

Society recognises outstanding achievements in microscopy, imaging and flow cytometry

Analytics, 22 September 2024
article-category

A quality boost from mass spectrometry for fermentation processes

Thermo Fisher Scientific discusses the role of process analytical technology in addressing the process challenges concerning fermentation and cell culture in biotechnology and enhancing quality and speed production

Analytics, 18 March 2024
article-category

Technological advances in MALDI imaging and spatial proteomics for medical research

Recent advancements in MALDI mass spectrometry imaging are transforming disease understanding and treatment. This innovation promises rapid diagnostics and personalised medicine, with reliable imaging within five years

Analytics, 18 March 2024

Conferences and Events

view more
article-category

Visitor Registration at the London Biotechnology Show 2025 is Live!

Join the UK’s leading biotechnology event to explore groundbreaking biotech innovations, connect with global healthcare leaders, and discover the future of life sciences for 𝐅𝐑𝐄𝐄.

Conferences and Events , 21 April 2025
article-category

ChinaBio Partnering Forum 2025: Connecting China’s Biotech with the Global Life Sciences Ecosystem

1 April 2025 -- Shanghai, China -- ChinaBio Partnering Forum, the largest and most productive life science partnering event in China, returns in 2025 with a hybrid format to facilitate global cross-border collaborations. The event will take place in person on April 23-24 at the Kerry Hotel Pudong in Shanghai, followed by a virtual edition on April 29-30, leveraging partneringONE™ to maximize engagement and dealmaking opportunities.

Conferences and Events , 31 March 2025
article-category

Industry Leaders Address Oncology Drugs and Biotech Funding - AAPS National Biotechnology Conference

26 March 2025 -- Virginia, US -- AAPS is excited to announce the opening and closing plenary speakers for the 2025 National Biotechnology Conference (NBC), taking place May 4-7 in Boston, MA.

Conferences and Events , 26 March 2025
article-category

ELRIG Announces Rory Johnson & Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides

25 March 2025 -- Cambridge, UK -- ELRIG, a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D site in Gothenburg, Sweden from 14–15 May.

Conferences and Events , 25 March 2025
article-category

The AAPS National Biotechnology Conference

The AAPS National Biotechnology Conference (NBC) uncovers the latest science and trends that impact today’s research and pharmaceutical markets, specifically in the areas of biologics, biotechnology products, and advanced therapies.

Conferences and Events , 2 December 2024

IPT TV

view more
article-category

Visitor Registration at the London Biotechnology Show 2025 is Live!

Join the UK’s leading biotechnology event to explore groundbreaking biotech innovations, connect with global healthcare leaders, and discover the future of life sciences for 𝐅𝐑𝐄𝐄.

IPT TV, 21 April 2025
article-category

⭐We're proud to be a BioFIT 2024 partner!

Come and join us for the 13th edition of BioFIT, on December 3rd & 4th, 2024 in Lille and digital meetings days on December 11th & 12th, 2024!

IPT TV, 9 October 2024
article-category

LSX Nordic Congress 2024

Showcasing innovation, accelerating investment and facilitating partnering for life science leaders in Northern Europe.

IPT TV, 8 September 2024
article-category

TIDES Europe: Oligonucleotide & Peptide Therapeutics

Accelerate Your Therapeutics to Market: Expedite R&D, Improve CMC Efficiency & Build New Partnerships Join the industry’s leading event in Europe and access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market.

IPT TV, 4 September 2024
article-category

World Orphan Drug Congress Europe 2024 Trailer

Join the world's leading orphan drug and rare disease Congress! 📅 22-25 October, 2024 📍Fira De Barcelona, Montjuic, Barcelona, Spain

IPT TV, 22 July 2024

Featured Content

view more
article-block

Turning an Ocean of Data Into Actionable Wisdom To Support Optimal Site Identification

Advancements in AI can help the pharmaceutical industry identify the best sites for their clinical trials through the harnessing of Big Data

 14 December 2022
Samedan